The rationale for the use of colchicine in COVID-19: comments on the letter by Cumhur Cure M et al

Clin Rheumatol. 2020 Aug;39(8):2489-2490. doi: 10.1007/s10067-020-05232-y. Epub 2020 Jun 20.

Silvia Piantoni^{1

2}, Enrico Colombo³, Paolo Airò⁴, Angela Tincani^{4

5}, Antonio Brucato⁶, Franco Franceschini^{4

5}, Laura Andreoli^{4

5}, Roberto Furloni³, Mirko Scarsi³

¹ Rheumatology and Clinical Immunology Unit, Department of Clinical and Experimental Sciences, ASST Spedali Civili and University of Brescia, Piazzale Spedali Civili 1, 25123, Brescia, Italy. slv.piantoni@gmail.com.
² Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy. slv.piantoni@gmail.com.
³ Internal Medicine Department, ASST Valcamonica, Esine, Brescia, Italy.
⁴ Rheumatology and Clinical Immunology Unit, Department of Clinical and Experimental Sciences, ASST Spedali Civili and University of Brescia, Piazzale Spedali Civili 1, 25123, Brescia, Italy.
⁵ Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
⁶ Department of Biomedical and Clinical Sciences "Sacco", University of Milano, Ospedale Fatebenefratelli, Milano, Italy.

No abstract available

Publication types